A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT05071664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of guselkumab plus golimumab combination treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) to prior anti-tumor necrosis factor-alpha (anti-TNF-alpha) therapies by assessing clinical response compared with guselkumab monotherapy.
Study identification
- NCT ID
- NCT05071664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2021 (Actual)
- Primary completion
- May 14, 2024 (Actual)
- Completion
- Aug 6, 2024 (Actual)
- Last update posted
- Jul 23, 2026
2021 – 2024
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Research PLLC | Phoenix | Arizona | 85032 | — |
| Arizona Arthritis and Rheumatology Research PLLC 1 | Phoenix | Arizona | 85037 | — |
| Unity Health-White County Medical Center | Searcy | Arkansas | 72143 | — |
| HARAC Research Corp | Avon Park | Florida | 33825 | — |
| Bay Pines VA Healthcare System | Bay Pines | Florida | 33744 | — |
| Omega Research Consultants | DeBary | Florida | 32713 | — |
| South Coast Research Center | Miami | Florida | 33136 | — |
| Advanced Clinical Research of Orlando | Ocoee | Florida | 34761 | — |
| Millennium Research | Ormond Beach | Florida | 32174 | — |
| Atlanta Research Center for Rheumatology | Marietta | Georgia | 30060 | — |
| Great Lakes Center of Rheumatology | Lansing | Michigan | 48911 | — |
| Clinvest | Springfield | Missouri | 65807 | — |
| NYU Langone Ambulatory Care Brooklyn Heights | Brooklyn | New York | 11201 | — |
| NYU School of Medicine | New York | New York | 10016 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| STAT Research, Inc. | Vandalia | Ohio | 45377 | — |
| Trinity Universal Research Associates, LLC | Plano | Texas | 75024 | — |
| DM Clinical Research | Tomball | Texas | 77375 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05071664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 23, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05071664 live on ClinicalTrials.gov.